MMedication Read More Large GLP-1 Drug Review Takes Closer Look at Risks, RewardsApril 1, 2026 Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks…
MMedication Read More FDA Approves Eli Lilly’s GLP-1 PillApril 1, 2026 The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,…
MMedication Read More Free Market Ozempic Will Make a Huge Difference to Tens of Millions of PeopleApril 1, 2026 Photo by David Trinks The New York Times had an interesting piece on the implications of Ozempic becoming…
MMedication Read More PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT DataApril 1, 2026 – PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
MMedication Read More Digant Sharma and Vibha Jain Launch Hypnotherapy Private LimitedApril 1, 2026 SMPL Mumbai (Maharashtra) [India], April 1: In a significant development for India’s mental wellness and holistic healing landscape,…
MMedication Read More List of Medications That Could Disqualify You From DrivingApril 1, 2026 Following news that Tiger Woods was carrying two hydrocodone pills—which are commonly prescribed for pain—when he was interviewed…
MMedication Read More Kerry pharmacist welcomes medicine blister packs agreementApril 1, 2026 A Kerry pharmacist has welcomed the agreement reached on medicine blister packs. The HSE and the Irish Pharmacy…
MMedication Read More FDA approves GLP-1 weight loss pill Foundayo from Eli LillyApril 1, 2026 The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe…
MMedication Read More New rules will make modern medications easier to access in CzechiaApril 1, 2026 Patients in Czechia will soon find it easier to access modern treatments for chronic conditions as the Ministry…
MMedication Read More Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details | India NewsApril 1, 2026 File photo: ANI NEW DELHI: The Centre has issued a detailed advisory on the use, risks and regulation…
MMedication Read More South Korea’s youngest children see sharpest rise in antidepressant useApril 1, 2026 SEOUL – The number of children and adolescents prescribed antidepressants in South Korea more than doubled in the…
MMedication Read More Central Council For Research In Ayurvedic Sciences, Anuvadini AI Bring Ayurveda Research In 13 LanguagesApril 1, 2026 The Central Council for Research in Ayurvedic Sciences (CCRAS) under Ayush Ministry on Monday signed a memorandum of…